Next Century Growth Investors LLC Pulmonx Corp Transaction History

Next Century Growth Investors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $23,270 - $36,368	1,516 Added 0.33%	454,614 $7.57 Million
Q2 2022 Aug 12, 2022	BUY	$14.0 - $27.95 $238,896 - $476,938	17,064 Added 3.91%	453,098 $6.67 Million
Q1 2022 May 13, 2022	BUY	$21.13 - $35.65 $5.56 Million - $9.39 Million	263,336 Added 152.48%	436,034 $10.8 Million
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $1.21 Million - $1.83 Million	40,647 Added 30.78%	172,698 $5.54 Million
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $4.75 Million - $5.87 Million	132,051 New	132,051 $4.75 Million
Q1 2021 May 14, 2021	SELL	$44.0 - $67.54 $2.36 Million - $3.62 Million	-53,664 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $2.11 Million - $3.7 Million	53,664 New	53,664 $3.7 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.